McKesson Is Closing a $2.25 Billion Precision Medicine Group Deal

The deal comes as McKesson’s fiscal 2027 adjusted earnings outlook stands at $45.60 to $46.40 per diluted share.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.